Natco Pharma Ltd. (NATCOPHARM) - Financials, balance sheet (quarterly)

827.90002 INR

2.8

0.34%

Last update May 14, 3:29 PM IST

Main market

Day range

827.90002

819.90002

834.34998

Previous close

825.099976

Open

832

Access this stock data via API

Natco Pharma Ltd.

827.90

2.80

0.34%

Financials

Balance sheet

Fiscal date	Sep 2024	Mar 2024	Sep 2023	Mar 2023
Total assets	82.4B	69.1B	62.5B	56.6B
Current assets	50.0B	40.2B	33.5B	30.0B
Cash	—	641M	—	1.3B
Cash equivalents	—	63M	—	0
Cash and cash equivalents	1.0B	704M	1.0B	1.3B
Other short term investments	23.6B	17.1B	11.1B	9.9B
Accounts receivable	14.4B	11.9B	11.2B	8.6B
Other receivables	101M	796M	89M	453M
Inventory	7.7B	7.0B	7.1B	7.4B
Prepaid assets	—	2.7B	—	2.3B
Restricted cash	—	31M	—	47M
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	0
Other current assets	3.2B	2.8B	3.0B	2.3B
Non current assets	32.4B	28.8B	29.0B	26.6B
Properties	23.0B	503M	22.7B	450M
Land and improvements	—	3.7B	—	2.9B
Machinery furniture equipment	—	18.3B	—	17.6B
Construction in progress	2.3B	1.4B	836M	643M
Leases	—	—	—	—
Accumulated depreciation	—	-10.6B	—	-9.1B
Goodwill	2.9B	2.5B	2.5B	2.4B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	1.8B	1.4B	1.4B	1.3B
Investments and advances	—	—	—	—
Other non current assets	584M	694M	481M	271M
Total liabilities	10.9B	10.5B	9.6B	7.8B
Current liabilities	10.1B	9.7B	8.8B	6.8B
Accounts payable	3.1B	2.4B	3.7B	2.6B
Accrued expenses	—	—	—	—
Short term debt	2.0B	3.8B	2.4B	1.8B
Deferred revenue	—	—	—	—
Tax payable	1.2B	323M	673M	101M
Pensions	—	1.0B	—	169M
Other current liabilities	1.8B	488M	739M	546M
Non current liabilities	792M	804M	822M	1.0B
Long term provisions	695M	709M	681M	853M
Long term debt	51M	53M	62M	11M
Provision for risks and charges	—	—	—	—
Deferred liabilities	2M	2M	46M	124M
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	—	-42.6B
Shareholders equity
Common stock	358M	358M	358M	365M
Retained earnings	—	44.7B	—	32.9B
Other shareholders equity	—	—	—	—
Total shareholders equity	71.6B	58.5B	52.9B	48.7B
Additional paid in capital	—	12.0B	—	14.1B
Treasury stock	—	—	—	—
Minority interest	69M	0	0	0